A Comparison of Underwater Versus Conventional Precoagulation Using Hybrid Knife in Peroral Endoscopic Myotomy for Esophageal Achalasia
Primary Purpose
Achalasia
Status
Not yet recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Coventional coagulation
Underwater coagulation
Peroral endoscopic myotomy
Sponsored by
About this trial
This is an interventional treatment trial for Achalasia
Eligibility Criteria
Inclusion Criteria: All >18 years-old patients undergoing POEM for esophageal achalasia Exclusion Criteria: patients on antithrombotic/anticoagulant therapy patients suffering from bleeding disorders patients with esophageal and/or gastric varices patients previously treated with POEM or Heller myotomy patients who were not able or refused to give informed written consent. vessels equal or more than the knife inner diameter (120 μm)
Sites / Locations
- Humanitas Research Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
POEM with conventional precoagulation
POEM with underwater precoagulation
Arm Description
POEM with conventional precoagulation
POEM with underwater precoagulation
Outcomes
Primary Outcome Measures
Bleeding
Rate of bleeding requiring the use of coagulation forceps
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05804266
Brief Title
A Comparison of Underwater Versus Conventional Precoagulation Using Hybrid Knife in Peroral Endoscopic Myotomy for Esophageal Achalasia
Official Title
A Randomized Comparison of Underwater Versus Conventional Precoagulation Using Hybrid Knife in Peroral Endoscopic Myotomy for Esophageal Achalasia
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 31, 2023 (Anticipated)
Primary Completion Date
April 30, 2024 (Anticipated)
Study Completion Date
April 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Istituto Clinico Humanitas
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Achalasia is an idiopathic esophageal motility disorder, characterized by the insufficient relaxation of the lower esophageal sphincter (LES) and the absence of peristalsis in the esophageal body, leading to disabling symptoms, such as dysphagia, regurgitation, chest pain and weight loss. Until a few years ago, common interventional therapeutic approaches included botulinum toxin injection, endoscopic pneumatic balloon dilation and laparoscopic Heller myotomy. Nevertheless, the first options have proved only limited efficacy, while the surgical approach is highly invasive, costly and burdened by potential severe complications and a long recovery.
First described by Inoue et al., peroral endoscopic myotomy (POEM) has recently been introduced as a novel treatment option. This innovative technique consists in creating a submucosal tunnel and cutting the esophageal muscular fibers with a less invasive approach than surgery. Due to the excellent clinical success rates achieved in both the short- and long-term with few adverse events, POEM has rapidly became one of the most common therapeutic approaches for esophageal achalasia. However, despite these great results, it is still an expensive, length, difficult and risky procedure.
Indeed, the creation of submucosal tunnel is hampered by frequent intra-procedural bleeding that makes the procedure troublesome and time-consuming, requiring often the need of costly hemostatic devices such as the coagulation forceps. Such risk may also become clinically relevant as it may lead to major delayed bleeding that in turn may require hospitalization, blood transfusions and retreatment of the patient.
No clear strategy to reduce the risk of intra-procedural and delayed bleeding has been put forward. Current practice consists of the preventive isolation and coagulation of the designed vessels during the submucosal tunneling.
What the investigator propose in this protocol is a new technique to prevent the risk of bleeding and make POEM easier, quicker, safer and cheaper. Indeed, the invetsigators noticed that preventive underwater coagulation of the candidate vessels during the submucosal tunneling with the Hybrid Knife (HK), may seal the wall of the vessel, resulting in a subsequent cut under CO2 without any bleeding. Such preventive coagulation is likely to be related with the conduction of the current underwater as it focalizes all the power on the interface between the vessel and the water, allowing a soft sealing of the vessel without cutting it.
The hypothesis of the investigators is that the implementation of this novel approach in clinical practice may lead to an increase in safety, feasibility and cost-effectiveness, reducing the procedural time, the rate of complications and the need for coagulation forceps in comparison with the conventional preventive coagulation technique under CO2 insufflation.
Therefore, this randomized study compares the novel underwater precoagulation technique with the conventional precoagulation technique in the CO2 setting during the submucosal tunneling.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Achalasia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
POEM with conventional precoagulation
Arm Type
Experimental
Arm Description
POEM with conventional precoagulation
Arm Title
POEM with underwater precoagulation
Arm Type
Experimental
Arm Description
POEM with underwater precoagulation
Intervention Type
Procedure
Intervention Name(s)
Coventional coagulation
Intervention Description
Coventional coagulation
Intervention Type
Procedure
Intervention Name(s)
Underwater coagulation
Intervention Description
Underwater coagulation
Intervention Type
Procedure
Intervention Name(s)
Peroral endoscopic myotomy
Intervention Description
Peroral endoscopic myotomy
Primary Outcome Measure Information:
Title
Bleeding
Description
Rate of bleeding requiring the use of coagulation forceps
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All >18 years-old patients undergoing POEM for esophageal achalasia
Exclusion Criteria:
patients on antithrombotic/anticoagulant therapy
patients suffering from bleeding disorders
patients with esophageal and/or gastric varices
patients previously treated with POEM or Heller myotomy
patients who were not able or refused to give informed written consent.
vessels equal or more than the knife inner diameter (120 μm)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alessandro Repici, MD
Phone
0039-02-82247493
Email
alessandro.repici@humanitas.it
Facility Information:
Facility Name
Humanitas Research Hospital
City
Milano
ZIP/Postal Code
20089
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alessandro Repici, MD
Phone
0039-02-82244507
Email
alessandro.repici@hunimed.eu
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
A Comparison of Underwater Versus Conventional Precoagulation Using Hybrid Knife in Peroral Endoscopic Myotomy for Esophageal Achalasia
We'll reach out to this number within 24 hrs